Engineering segment H2 revenue and margins to mirror H1
Management expects the first-half performance (revenue growth ~7%, margins ~4.8%) to broadly continue in the second half of FY26.
ION Exchange (India) · forward-looking guidance across the available source record.
Guidance tracker
Management expects the first-half performance (revenue growth ~7%, margins ~4.8%) to broadly continue in the second half of FY26.
Management guided for 9-10% year-on-year growth in the chemical segment for the full year, maintaining favorable profitability mix.
The greenfield resin plant at Roha will be fully commissioned by the end of the financial year, with gradual scale-up over 3-4 years.
Excluding the Roha plant, total capex for the year is expected to be around ₹80-100 crore, primarily in existing manufacturing and membrane facilities.
Deferred international project dispatches expected to execute in Q4, boosting revenue and profitability.
Management expects to achieve 25% capacity utilization of the Roha resin plant in the next financial year.
With continued 30% growth and investment, the division could approach breakeven next year.
Management expects to achieve 25% capacity utilization at the Roha plant in the first full year of operation, despite short-term raw material headwinds.
Management expects the consumer products division to at least break even or post a small profit in FY27, driven by continued revenue growth and operational improvements.
The legacy project (Sri Lanka) is expected to be completed by the end of Q2 FY27, with the balance execution continuing in the current financial year.
Management guided for routine maintenance capex of INR 30-40 crore in FY27, with no major new capex planned unless for further expansion.